Skip to main content

Table 3 Comparison of the Glycemic variability indices and AHI in the study population

From: A study of glycemic variability in patients with type 2 diabetes mellitus with obstructive sleep apnea syndrome using a continuous glucose monitoring system

VARIABLEGroup A (n = 20)
Mean ± SD
Group B
(n = 20)
Mean ± SD
Group C
(n = 10)
Mean ± SD
Group D
(n = 10)
Mean ± SD
AHI18.97 ± 13.593.50 ± 1.3418.98 ± 13.723.51 ± 1.15
Time in Range (%)67 ± 4.2669 ± 3.5489 ± 2.7197 ± 1.33
Time above Range (%)20 ± 2.519 ± 2.88 ± 1.20
Time below range (%)13 ± 2.112 ± 1.83 ± 1.42 ± 0.5
Mean Glucose (mmol/L)7.77 ± 2.426.81 ± 2.315.85 ± 2.104.83 ± 1.95
SD (mmol/L)2.44 ± 1.101.91 ± 0.860.87 ± 0.160.68 ± 0.11
CV (%)31% ± 4.528% ± 3.516% ± 2.814% ± 2.4
Night Mean glucose (mmol/L)6.84 ± 1.826.70 ± 1.645.05 ± 0.204.70 ± 0.15
Night SD (mmol/L)2.54 ± 1.761.96 ± 0.920.98 ± 0.140.74 ± 0.14
Night CV (%)37 ± 2.529 ± 2.319 ± 1.215 ± 1.1
MAGE (mmol/L)5.20 ± 2.152.67 ± 1.042.47 ± 0.420.77 ± 0.19
NMAGE (mmol/L)5.78 ± 2.162.22 ± 1.002.85 ± 0.420.62 ± 0.15
  1. One way ANOVA applied, data failed normality hence Kruskal Wallis test applied
  2. P value was significant between all four groups
  3. P <  0.05 was considered significant
  4. Time in Range: 3.9 to 10 mmol/L, Time Below range: < 3.9 mmol/L, Time above range > 10 mmol/L